Copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.2006
We read with interest the article by Dodd et al.1 Impulse control disorders associated with dopaminergic drugs in Parkinson disease (PD) are fascinating and of considerable clinical importance. This report, however, focuses on dopamine agonists and especially pramipexole. Although dopamine agonists are more commonly implicated in impulse control disorders, we would like to point out that levodopa is associated with similar behaviors as well.2-4
Morgan JC, Iyer SS, Sethi KD. Impulse Control Disorders and Dopaminergic Drugs. Arch Neurol. 2006;63(2):298–299. doi:10.1001/archneur.63.2.298-b
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: